Avanda Investment Management Pte. Ltd. Purchases 2,400 Shares of Lam Research Corporation $LRCX

Avanda Investment Management Pte. Ltd. raised its holdings in Lam Research Corporation (NASDAQ:LRCX) by 51.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 7,100 shares of the semiconductor company’s stock after acquiring an additional 2,400 shares during the quarter. Lam Research makes up about 2.4% of Avanda Investment Management Pte. Ltd.’s portfolio, making the stock its 14th largest holding. Avanda Investment Management Pte. Ltd.’s holdings in Lam Research were worth $1,517,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in LRCX. PMV Capital Advisers LLC bought a new position in Lam Research during the 4th quarter worth approximately $25,000. Stance Capital LLC bought a new stake in shares of Lam Research in the 3rd quarter valued at $26,000. Bayban bought a new stake in shares of Lam Research in the 4th quarter valued at $26,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Lam Research during the first quarter worth $26,000. Finally, Cedar Mountain Advisors LLC increased its position in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after buying an additional 85 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Stock Up 4.9%

Lam Research stock opened at $346.10 on Wednesday. The company has a quick ratio of 1.77, a current ratio of 2.54 and a debt-to-equity ratio of 0.35. Lam Research Corporation has a 12-month low of $90.93 and a 12-month high of $438.50. The firm’s fifty day moving average is $337.74 and its 200 day moving average is $266.51. The company has a market capitalization of $432.82 billion, a PE ratio of 65.30, a PEG ratio of 1.95 and a beta of 1.80.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The business had revenue of $5.84 billion during the quarter, compared to analysts’ expectations of $5.70 billion. During the same period last year, the company posted $1.04 earnings per share. The business’s quarterly revenue was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 5.68 EPS for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th were paid a $0.26 dividend. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 annualized dividend and a dividend yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is currently 19.62%.

Insider Transactions at Lam Research

In other Lam Research news, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares in the company, valued at approximately $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 104,621 shares of company stock valued at $33,804,737. 0.31% of the stock is currently owned by corporate insiders.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Mizuho raised its price target on Lam Research to $400 from $380 and kept an Outperform rating, saying AI demand should support durable wafer fab equipment spending through 2027-2029. Mizuho Raises its Price Target on Lam Research Corporation (LRCX)
• Positive Sentiment: Analysts and market commentary continue to highlight Lam Research as a beneficiary of AI-related spending, with recent reports pointing to strong demand in HBM, advanced DRAM, and leading-edge chips. Can AI Chip Boom Help LRCX Reach Record Q4 Sales Target of $6.6B?
• Positive Sentiment: QuiverQuant noted the stock is benefiting from improving sentiment across chip-equipment names ahead of Lam Research’s late-July earnings report, which is encouraging traders to rotate back into the group. Lam Research Rises as Chip-Equipment Sentiment Improves Ahead of Earnings
• Neutral Sentiment: Jim Cramer’s recent comments and other media coverage have kept Lam Research in the spotlight, but these articles are mostly reinforcing the bullish AI narrative rather than introducing new company-specific news. Jim Cramer Shares Why am Research Corporation (LRCX) is on Fire
• Negative Sentiment: There is still some near-term caution in the background, including recent weakness tied to cooling AI memory enthusiasm and ongoing semiconductor volatility, which could limit upside if capital spending slows. Lam Research (LRCX) Stock Slides As AI Memory Boom Loses Steam
• Negative Sentiment: Director Abhijit Y. Talwalkar sold 18,282 shares in a pre-arranged Rule 10b5-1 transaction, which may modestly temper sentiment even though the sale was planned. Lam Research director stock sale

Analysts Set New Price Targets

A number of equities analysts recently weighed in on LRCX shares. Wells Fargo & Company reissued an “overweight” rating and set a $450.00 target price (up from $365.00) on shares of Lam Research in a research note on Monday, June 22nd. B. Riley Financial upped their price target on shares of Lam Research from $350.00 to $375.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. BNP Paribas Exane increased their price target on Lam Research from $250.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, April 23rd. Morgan Stanley lifted their price objective on Lam Research from $331.00 to $404.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, New Street Research boosted their price objective on Lam Research from $235.00 to $280.00 and gave the company a “neutral” rating in a research note on Monday, April 27th. Twenty-eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and an average price target of $358.67.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.